Clean Science and Technology to Review Q2 FY27 Results
Key highlights
- Clean Science will review unaudited Q2 FY27 and first-half FY27 results on October 31, 2026, for the period ended September 30, 2026.
- Clean Science reported June 2026 net sales of ₹268.43 crore, up about 10.5% from ₹242.87 crore a year earlier.
- Clean Science reported June 2026 EBITDA of ₹118.65 crore and profit after tax of ₹73.35 crore.
- Clean Science shares closed at ₹716.60 on October 30, 2026, down 3.02% for the session.
powered by IRIS

Clean Science and Technology Limited will hold a board meeting on October 31, 2026, to consider unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. The meeting follows June-quarter net sales of ₹268.43 crore, up from ₹242.87 crore a year earlier, while the share closed at ₹716.60 on October 30.
Know Clean Science & Technology inside out
Results, valuation, peers and who's buying, in one view.
When will Clean Science review its Q2 FY27 results?
Clean Science will convene its Board of Directors on Saturday, October 31, 2026, to consider and approve unaudited financial results for the September 2026 quarter and the first half of FY27. The company disclosed the meeting through filings with BSE Limited and the National Stock Exchange of India Limited on October 17.
The agenda covers both standalone and consolidated financial statements. The notice does not provide the September-quarter revenue, profit, margin, volume, or guidance figures. Those details are expected only when the board-approved results are released.
The timing is relevant because the September quarter completes the first half of the financial year. Investors will be able to compare the reported figures with the June quarter and the September 2025 quarter once the company publishes the financial statements.
Why is Clean Science's trading window closed?
Clean Science closed its trading window for designated persons from October 1, 2026. The window will reopen 48 hours after the unaudited results are announced, according to the company’s disclosure.
A trading-window closure restricts dealing in the company’s securities by designated persons during a period when unpublished price-sensitive information may be available. In this case, the restriction is linked to the preparation and approval of the September-quarter and half-year results.
The closure does not indicate the direction of the forthcoming financial performance. It is a disclosed compliance measure ahead of the board’s consideration of the results and remains in place until the stated period after the announcement.
Got a follow-up? Ask IRIS
What do Clean Science's latest reported quarterly figures show?
Clean Science reported net sales turnover of ₹268.43 crore for the quarter ended June 2026, compared with ₹242.87 crore in the June 2025 quarter. This represents a year-on-year increase of about 10.5% based on the figures provided in the company’s quarterly data.
Reported profit after tax was ₹73.35 crore in the June 2026 quarter, against ₹70.06 crore a year earlier. EBITDA was ₹118.65 crore, compared with ₹113.28 crore in the corresponding prior-year period, while operating profit was ₹96.43 crore versus ₹99.85 crore.
The June 2026 results also showed an improvement from the immediately preceding March 2026 quarter. Net sales were ₹249.25 crore in March 2026, reported PAT was ₹58.27 crore, and EBITDA was ₹98.56 crore. The upcoming September-quarter release will provide the next reported comparison point.
How did Clean Science shares trade before the board meeting?
Clean Science shares closed at ₹716.60 on BSE on October 30, 2026, down ₹22.35 or 3.02% for the session. This was the market price available immediately before the scheduled board meeting.
The board notice itself does not state a reason for the share-price movement. It also does not contain an earnings forecast or a management assessment of the September-quarter performance. Therefore, the announced financial results will be the relevant official update for assessing the company’s reported operating and financial position.
For shareholders, the release will add the first-half figures to the available June-quarter data. The standalone and consolidated disclosures may also allow market participants to examine changes in income, operating profit, EBITDA, tax expense and reported profit across the recent periods.
Conclusion
Clean Science is scheduled to consider its Q2 FY27 and first-half FY27 unaudited results on October 31, following June-quarter net sales of ₹268.43 crore and reported PAT of ₹73.35 crore. The company’s trading-window closure remains effective through 48 hours after the result announcement, while its shares closed 3.02% lower at ₹716.60 on October 30.
The next item to watch is the board-approved release of the standalone and consolidated results for the quarter and half year ended September 30, 2026. The disclosure will clarify how the September period compares with the June 2026 quarter and the September 2025 quarter on revenue, profitability and other reported financial measures.


